Shannon L. Devers - Sep 29, 2024 Form 3 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role
EVP, Chief Human Resourses Ofc
Signature
By: Patrick R. O'Neil, attorney-in-fact For: Shannon L. Devers
Stock symbol
IONS
Transactions as of
Sep 29, 2024
Transactions value $
$0
Form type
3
Date filed
10/1/2024, 06:01 PM
Next filing
Oct 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IONS Common Stock 7.91K Sep 29, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IONS Non-Qualified Stock Option (right to buy) Sep 29, 2024 Common Stock 14.4K $32.60 Direct
holding IONS Non-Qualified Stock Option (right to buy) Sep 29, 2024 Common Stock 15.3K $37.58 Direct
holding IONS Non-Qualified Stock Option (right to buy) Sep 29, 2024 Common Stock 6K $48.51 Direct
holding IONS Non-Qualified Stock Option (right to buy) Sep 29, 2024 Common Stock 16K $49.25 Direct
holding IONS Non-Qualified Stock Option (right to buy) Sep 29, 2024 Common Stock 18.5K $52.87 Direct
holding IONS Non-Qualified Stock Option (right to buy) Sep 29, 2024 Common Stock 16.8K $53.77 Direct
holding IONS Non-Qualified Stock Option (right to buy) Sep 29, 2024 Common Stock 28.5K $56.78 Direct
holding IONS Non-Qualified Stock Option (right to buy) Sep 29, 2024 Common Stock 17.1K $60.89 Direct
holding IONS Restricted Stock Unit Sep 29, 2024 Common Stock 31.2K $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
F2 Grants to reporting person of restricted stock units under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan on January 15, 2021, January 15, 2022, January 15, 2023 and January 15, 2024. The restricted stock units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.